DrugPatentWatch Database Preview

PF PRISM CV Company Profile

« Back to Dashboard

What is the competitive landscape for PF PRISM CV, and when can generic versions of PF PRISM CV drugs launch?

PF PRISM CV has seventeen approved drugs.

There are forty-four US patents protecting PF PRISM CV drugs.

There are nine hundred and ninety-five patent family members on PF PRISM CV drugs in sixty-seven countries and ninety-three supplementary protection certificates in sixteen countries.

Summary for PF PRISM CV

International Patents:	995
US Patents:	44
Tradenames:	13
Ingredients:	12
NDAs:	17

Drugs and US Patents for PF PRISM CV

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pf Prism Cv	TYGACIL	tigecycline	POWDER;INTRAVENOUS	021821-001	Jun 15, 2005	AP	RX	Yes	Yes	8,372,995		Y
Pf Prism Cv	PRISTIQ	desvenlafaxine succinate	TABLET, EXTENDED RELEASE;ORAL	021992-002	Feb 29, 2008	AB	RX	Yes	Yes
Pf Prism Cv	BOSULIF	bosutinib monohydrate	TABLET;ORAL	203341-003	Oct 27, 2017		RX	Yes	No	7,919,625		Y
Pf Prism Cv	LYRICA CR	pregabalin	TABLET, EXTENDED RELEASE;ORAL	209501-001	Oct 11, 2017		RX	Yes	No
Pf Prism Cv	LYRICA	pregabalin	CAPSULE;ORAL	021446-007	Dec 30, 2004		RX	Yes	No	6,001,876*PED
Pf Prism Cv	LYRICA	pregabalin	CAPSULE;ORAL	021446-004	Dec 30, 2004		RX	Yes	No
Pf Prism Cv	LYRICA CR	pregabalin	TABLET, EXTENDED RELEASE;ORAL	209501-001	Oct 11, 2017		RX	Yes	No	10,022,447*PED				Y

Expired US Patents for PF PRISM CV

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pf Prism Cv	RAPAMUNE	sirolimus	TABLET;ORAL	021110-001	Aug 25, 2000	5,308,847*PED
Pf Prism Cv	VFEND	voriconazole	INJECTABLE;IV (INFUSION)	021267-001	May 24, 2002	5,567,817
Pf Prism Cv	RAPAMUNE	sirolimus	TABLET;ORAL	021110-001	Aug 25, 2000	5,989,591*PED
Pf Prism Cv	VFEND	voriconazole	TABLET;ORAL	021266-002	May 24, 2002	5,567,817
Pf Prism Cv	VFEND	voriconazole	TABLET;ORAL	021266-002	May 24, 2002	5,364,938
Pf Prism Cv	VFEND	voriconazole	INJECTABLE;IV (INFUSION)	021267-001	May 24, 2002	5,116,844
Pf Prism Cv	VFEND	voriconazole	INJECTABLE;IV (INFUSION)	021267-001	May 24, 2002	5,134,127

Paragraph IV (Patent) Challenges for PF PRISM CV drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Tablets	330 mg		2018-01-29
	Extended-release Tablets	330 mg		2018-01-29
	Extended-release Tablets	50 mg and 100 mg		2012-02-29
	Tablets	100mg and 500mg		2016-09-06
	Capsules	25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg		2008-12-30
	Tablets	0.5 mg and 1 mg		2010-05-10
	For Injection	200 mg/vial		2008-09-12
	Tablets	5 mg		2016-11-07
	Oral Suspension	40 mg/mL		2010-10-08
	Injection	25 mg/mL, 1.8 mL vial		2011-05-25
	Tablets	0.5 mg		2010-08-25
	Extended-release Tablets	82.5 mg and 165 mg		2018-02-02
	Extended-release Tablets	82.5 mg and 165 mg		2018-02-02
	Extended-release Tablets	25 mg		2015-05-08
	Tablets	400 mg		2018-10-15
	Oral Solution	20 mg/mL		2010-05-19
	Tablets	1 mg and 5 mg		2018-02-23
	Tablets	50 mg and 200 mg		2008-04-14
	For Injection	50 mg per vial		2009-06-15
	Tablets	1 mg and 2 mg		2009-12-17

International Patents for PF PRISM CV Drugs

Country	Patent Number	Estimated Expiration
Norway	20024042
Estonia	05585
New Zealand	519973
South Korea	101237588
South Korea	100869409
Morocco	27713
Japan	2010132700

Supplementary Protection Certificates for PF PRISM CV Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1666481	300887	Netherlands		PRODUCT NAME: TOFACITINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER TOFACITINIBCITRAAT; REGISTRATION NO/DATE: EU/1/17/1178 20170324
1044189	PA2008010,C1044189	Lithuania		PRODUCT NAME: VARENICLINUM TARTRAT; REGISTRATION NO/DATE: EU/1/06/360/001 - EU/1/06/360/010, 0060926
1218348	1390007-1	Sweden		PRODUCT NAME: AXITINIB, VALFRITT I FORM AV ETT FARMACEUTISKT GODTAGBART SALT; REG. NO/DATE: EU/1/12/777/001 20120903
1044189	122008000038	Germany		PRODUCT NAME: VARENICLIN GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES UNTER EINSCHLUSS VON TARTRAT; REGISTRATION NO/DATE: EU/1/06/360/001-010 20060926
1044189	325	Finland
1902029	C20140016 00110	Estonia		PRODUCT NAME: BOSUTINIIB;REG NO/DATE: K(2013)1968 (LOPLIK) 02.04.2013
1666481	1790038-2	Sweden		PRODUCT NAME: TOFACITINIB, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE CITRATE SALT; REG. NO/DATE: EU/1/17/1178 20170324

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Pf Prism Cv